# EDGAR Filing Document

**Accession Number:** 0001734005
**File Stem:** 0001213900-23-004938
**Filing Date:** 2023-1
**Character Count:** 4483
**Document Hash:** 08d2f8a1d8ccbeb7d7ff8e0a9c540430
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-004938.hdr.sgml**: 20230125

**ACCESSION NUMBER**: 0001213900-23-004938

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230124

**FILED AS OF DATE**: 20230125

**DATE AS OF CHANGE**: 20230124

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aptorum Group Ltd
- **CENTRAL INDEX KEY:** 0001734005
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38764
- **FILM NUMBER:** 23549439

**BUSINESS ADDRESS:**
- **STREET 1:** 17 HANOVER SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1S 1BN
- **BUSINESS PHONE:** 852 3953 7700

**MAIL ADDRESS:**
- **STREET 1:** 17 HANOVER SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1S 1BN

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 6-K** 

**REPORT OF FOREIGN PRIVATE ISSUER** 

**PURSUANT TO RULE 13a-16 OR 15d-16** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934** 

**For the month of January 2023** 

Commission File Number: **001-38764**

**APTORUM GROUP LIMITED**

**17 Hanover Square**

**London W1S 1BN, United Kingdom**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

On January 23, 2023, Aptorum Group, Inc. (the "**Company**") was notified that trading of its Class A Ordinary Shares, par value $10.00 per share on the Euronext Paris (Euronext Paris: APM), has been suspended as of that same date, so that the Company can update its information on the Euronext website to be consistent with the information on Nasdaq and to properly reflect the recently announced reverse stock split.

The Company's Class A Ordinary Shares continue to trade on The Nasdaq Global Market under the symbol "APM" at this time and we do not believe that will be affected by the suspension mentioned above.

.

The Company is working with Euronext Paris and the relevant agencies to update the appropriate information reflecting the reverse stock split and have its information updated on the Euronext website as soon as possible before resuming trading on the Euronext.

This report shall not constitute an offer to sell, or the solicitation of an offer to buy our securities, nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

The information in this Form 6-K shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

This Form 6-K is hereby incorporated by reference into the registration statements of the Company on Form S-8 (Registration Number [333-232591](http://www.sec.gov/Archives/edgar/data/1734005/000121390019012430/fs82019_aptorumgrouplimited.htm)) and Form F-3 (Registration Number [333-268873](http://www.sec.gov/Archives/edgar/data/1734005/000121390022080746/ea170215-f3_aptorumgroup.htm)) and into each prospectus outstanding under the foregoing registration statements, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **Aptorum Group Limited** | **Aptorum Group Limited** | **Aptorum Group Limited** |
| Date: January 24, 2023 | By: | /s/ Darren Lui | /s/ Darren Lui |
|  |  | Name: | Darren Lui |
|  |  | Title: | Chief Executive Officer |

---